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Saline-Enhanced Radiofrequency
Thermal Ablation of the Lung:
A Feasibility Study in Rabbits
Objective: To assess the feasibility and safety of CT-guided percutaneous
transthoracic radiofrequency ablation (RFA) with saline infusion of pulmonary tis-
sue in rabbits.
Materials and Methods: Twenty-eight New Zealand White rabbits were divid-
ed into two groups: an RFA group (n=10) and a saline-enhanced RFA (SRFA)
group (n=18). In the RFA group, percutaneous RFA of the lung was performed
under CT guidance and using a 17-gauge internally cooled electrode. In the
SRFA group, 1.5 ml of 0.9% saline was infused slowly through a 21-gauge, poly-
teflon-coated Chiba needle prior to and during RFA. Lesion size and the healing
process were studied in rabbits sacrificed at times from the day following treat-
ment to three weeks after, and any complications were noted.
Results: In the SRFA group, the mean diameter (12.5 1.6 mm) of acute RF
lesions was greater than that of RFA lesions (8.5 1.4 mm) (p < .05). The compli-
cations arising in 12 cases were pneumothorax (n=8), thermal injury to the chest
wall (n=2), hemothorax (n=1), and lung abscess (n=1). Although procedure-relat-
ed complications tended to occur more frequently in the SRFA group (55.6%)
than in the RFA group (20%), the difference was not statistically significant (p =
.11).
Conclusion: Saline-enhanced RFA of pulmonary tissue in rabbits produces
more extensive coagulation necrosis than conventional RFA procedures, without
adding substantial risk of serious complications.
mage-guided radiofrequency thermal ablation is a rapidly evolving, mini-
mally invasive technique used for the treatment of focal malignant dis-
eases (1 4). In this respect, promising results have been reported in cases
involving various solid tumors in different organs, especially in the treatment of prima-
ry and secondary hepatic malignancies (5 12). The recently published results of ra-
diofrequency ablation (RFA) for the treatment of primary and secondary lung malig-
nancies are encouraging, though the two reported studies included only a few cases
and follow-up was limited (13, 14). The potential benefits of these techniques com-
pared with conventional surgical options or radiation therapy for the treatment of lung
malignancies include tumor ablation in nonsurgical candidates, reduction of the mor-
bidity associated with surgery or radiation therapy, and the fact that the procedure can
be performed on an outpatient basis.
The considerable differences in tissue characteristics between the lung and other sol-
id organs such as the liver or kidneys influence the outcome of RFA, and this must be
borne in mind when the technique is used for the treatment of lung malignancies. First,
air-containing lung tissue has a naturally high tissue impedance, and the creation of a
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Isurgical margin around the tumor may thus be difficult, a
fact which might be related to the high local recurrence
rate (6, 15 17). In addition, in cases of oval-shaped lung
tumor, in which additional placement of an RF electrode at
the tumor margin may be needed if complete necrosis is to
be achieved, projection of the electrode tip into lung tissue
could induce a rapid increase in impedance and limit the
effectiveness of RFA. Furthermore, to prevent pneumotho-
rax, the number of electrical passes through the pleural
surface should be minimized during RF ablation of the
lung. To minimize possible local recurrence at the tumor
margin, and thus the occurrence of pneumothorax, it is,
therefore, necessary to induce more extensive thermal
necrosis with one RF ablation procedure. Previous studies
of saline-enhanced RFA of the liver (18 19) have shown
that the use of saline allows thermal energy to spread fur-
ther and faster in tissue, and increases tissue ionicity, there-
by permitting greater current flow. To our knowledge,
however, the literature contains the report of saline-en-
hanced RFA of the lung.
The purpose of this investigation is to assess the technical
feasibility and safety of CT-guided transthoracic RFA with
simultaneous saline infusion in rabbit lung.
MATERIALS AND METHODS
Animal Preparation 
Twenty-eight male New Zealand white rabbits weighing
2.5 3 kg were anesthetized by intramuscular injection of
50 mg/kg ketamine hydrochloride (Ketamine ; Yuhan,
Seoul, Korea) and 5 mg/kg xylazine (Rumpun ; Bayer
Korea, Ansan, Korea) prior to RFA and other procedures.
Booster injections of up to one-half of the initial dose were
administered as needed. The upper back and lower abdom-
inal areas were shaved and sterilized, and each animal was
placed in the prone position on the CT table.
To assess the feasibility and safety of saline-enhanced
RFA of normal lung parenchyma compared to convention-
al RFA, rabbits were allocated to either the RFA group
(n=10) or the saline-enhanced RFA (SRFA) group (n=18).
In addition, to compare the histopathologic change in lung
parenchyma following SRFA and the occurrence of de-
layed complications, the rabbits in the SRFA group were
allocated to either an acute (n=10) or subacute subgroup
(n=8), and sacrificed at different time intervals after the
procedure. In the RFA group (n=10) and the acute sub-
group of the SRFA group (n=10), unilateral lung RFA was
performed in 20 rabbits and all were sacrificed on the day
of the procedure. During the subacute phase, eight rabbits
were sacrificed on day 7 (n=2), or day 10 (n=2), and at two
(n=2) or three weeks (n=2) after RFA.
RF Ablation Procedure
A Somatom Plus-4 CT scanner (Siemens, Erlangen,
Germany) was used to obtain axial scans (2-mm slice thick-
ness and 1.0 1.5 pitch) of the entire lung field, and the
target portion and appropriate approach route for saline
infusion and RFA were thus determined. In the saline infu-
sion group, a polyteflon-coated 21-gauge Chiba needle
(M.I.Tech, Seoul, Korea) was used for 0.9% saline infusion
before and during the application of RF energy.
An internally cooled, 17-gauge electrode (Radionics;
Burlington, Mass., U.S.A.) with a 1- or 2-cm active tip was
placed in the target area of the lung under CT guidance,
and the Chiba needle was inserted using the tandem tech-
nique (20). To maximize the effects of saline instillation,
the tip of the needle was placed 3 mm posterior to the tip
of the RF electrode. To confirm the position of the needle
and the electrode in the target area, CT scanning was per-
formed. Saline (0.5 mL) was then infused at a rate of 0.1
mL/sec prior to the application of RF energy, and to avoid
bronchial aspiration, 1 mL saline at a rate of 0.05 mL/sec
was also infused during RFA after frequent pulsing began.
An electrode with a 1-cm active tip was used in rabbits in
the RFA and SRFA groups to evaluate the immediate ef-
fects of RFA, while the electrode used in the subacute sub-
group to evaluate histopathologic change and delayed
complications had a 2-cm active tip.
Lesions were created using a 500-kHz RF generator (CC-
3; Radionics) capable of producing 200 W of power. For
analyzing the adverse effects of RF energy on lung
parenchyma, ablated lesions were induced in the central
portion of the lung in 14 rabbits and in its peripheral por-
tion in the other 14. During the procedure, a thermocouple
embedded within the electrode tip continuously measured
the local tissue temperature, and tissue impedance was
monitored by circuitry incorporated within the generator.
A peristaltic pump (Watson-Marlow; Medford, Mass.,
U.S.A.) was used to infuse normal saline solution at 0 in-
to the lumen of the electrode at a rate of 10 25 mL/min,
and this was sufficient to maintain a tip temperature of
20 25 . When the desired current could not be applied
due to a rapid elevation of impedance suggestive of tissue
boiling, the generator automatically switched to the
pulsed-RF technique (21). Power output was set at 30 W,
and RF energy was applied for approximately five minutes
on the basis of our earlier study findings (22).
Postprocedural Follow-up
Using the same scanner and starting two hours after RFA
(day 0), Spiral CT scans were obtained to monitor the ef-
fects of ablation and to observe morphological change in
the lesions at weeks 1, 2, and 3 after RFA. Axial scans (2-
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upper abdomen, including the kidneys, were obtained be-
fore and after the injection of contrast medium (6 9 mL,
Ultravist 370 ; Schering, Berlin, Germany) at a rate of 1
mL/sec through the ear vein. Post-contrast CT scans were
obtained 30 and 60 secs after contrast administration. The
diameters of the ablated lesions were measured on PACS
images by one radiologist using an electric caliper. 
Imaging Analysis: Two radiologists experienced in body
imaging reviewed pre- and post-ablation CT images of all
animals. They interpreted these side by side, and in each
case reached a consensus. Each RFA lesion was evaluated
in terms of its location, size and shape, attenuation change,
and the presence of hemorrhage or air in the pleural cavi-
ty, and then classified as either central (inner 2/3) or pe-
ripheral (outer 1/3), depending on its location. To ensure
that the changes noted were not present before RFA, the
post- and preprocedural CT findings were compared.
Histopathologic examination: After spiral CT examina-
tion, rabbits were sacrificed at various points in time by in-
jection of an overdose of Ketamine and Xylazine, and their
lungs were harvested. The gross specimens obtained were
dissected in planes similar to those of the spiral CT scans,
and were examined. For macroscopic examination, two
observers, who reached a consensus, used calipers to mea-
sure the central discolored region of coagulation necrosis in
each pathologic specimen. Tissues were then fixed in 10%
formalin for routine histologic examination, and final pro-
cessing for light microscopic study involved paraffin sec-
tioning and hematoxylin-eosin (HE) staining. Tissues ob-
tained from all treatment areas were analyzed for nonvia-
bility, their histologic appearance, and demarcation from
surrounding viable tissue. A surgical pathologist and a radi-
ologist evaluated the gross and microscopic findings at
each RFA site, and reached a consensus.
Data Analysis
The technical aspects of RFA (namely, total time needed
for the procedure and current or impedance changes occur-
ring) and complications arising were compared for both
techniques. For all statistical analysis, SPSS 9.0 computer
software (SPSS Inc., Chicago, Ill., U.S.A.) was used. The
size of the acute RF lesions in the two groups was com-
pared using an unpaired Student’s t test. All contingency
data were analyzed using the chi-square test, or Fisher’s
exact test for fewer than five observed events. For all sta-
tistical analysis, a p value of less than 0.05 was considered
statistically significant.
RESULTS
RFA was technically successful in all instances, and 28 le-
sions were created with or without saline infusion. No
anesthesia- or procedure- related deaths occurred.
Technical Parameters
Since the tip of the RF electrode or Chiba needle was
easily localized at CT, its positioning was not difficult. The
time required for correct needle placement ranged from
1.5 to 3.5 (mean, 2.3 0.6) minutes for RFA and from 2.7
to 4.5 (mean, 3.4 1.5) minutes for SRFA (p = .04). 
In the RFA group, mean initial tissue impedance was 187
24 ,and in the SRFA group, after instillation of 0.5 mL
of normal saline, the reading decreased to 134 24
(p < .05). In the RFA group, tissue impedance changed
markedly (from 200 to 1000 ) during the procedure and
frequently induced activation of the pulsing technique,
whereas in the SRFA group, impedance showed no notable
change (range, 100 500 ). Without saline infusion, as in
the RFA group, impedance rose abruptly within a mean
period of 20 4.5 seconds. This automatically initiated RF
pulsing, which was followed by alternating 5 10-second
periods of high-energy deposition and approximately 15-
second periods of low energy deposition. With saline infu-
sion prior to and during RFA (SRFA group), impedance re-
mained constantly low (at approximately 100 ) during
the first 1 2 minutes of RF energy instillation, but an
abrupt rise which induced RF pulsing occurred during the
second half of the procedure (at mean 107 54 seconds).
Additional infusion of saline after the initiation of RF puls-
ing led to a lower rise in impedance and extended the time
of continuous RF energy application. Differences between
the two groups in the duration of RF energy instillation be-
fore pulsing were statistically significant: 20 4.5 vs. 107
54 seconds (p < .05).
The Effects of Tissue Ablation, and Complications
In the SRFA and RFA groups, the mean maximum diam-
eters of acute lesions induced by a 1-cm active tip, as mea-
sured in gross specimens, were 12.5 1.6 and 8.5 1.4
mm, respectively; this difference between the two groups
was statistically significant (p < .05) (Table 1). In the SRFA
group, the mean maximum diameter of subacute lesions in-
duced by a 2-cm active tip was 21.3 5.8 cm (p < .05).
The complications occurring after RFA are summarized
in Table 2, and were as follows: pneumothorax (n=8); ther-
mal injury to the chest wall (n=2); hemothorax (n=1); and
lung abscess (n=1). Three pneumothoraces were large
(with lung volume decrease due to pleural air collection
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small (perilesional small air collection, with no evidence of
respiratory distress). Complications tended to occur more
frequently in the SRFA group (55.6%, 10/18) than in the
RFA group (20%, 2/10), though the difference was not sta-
tistically significant (p = .11). However, complication rates
varied between the two groups, depending on the location
of the lesions. Among central lesions, large pneumothorax
occurred in two rabbits in the RFA group (20%, 2/10) and
in one in the SRFA group (5.6%, 1/18) (p = .28). Among
peripheral lesions, on the other hand, the complication rate
was much higher in the SRFA group (77.8%) than in the
RFA group (p = .02). The complications involved included
thermal injury to the chest wall, and one lung abscess.
The incidence rates of complications, namely 35.7%
(5/14) for centrally located lesions and 50% (7/14) for pe-
ripherally located lesions, did not differ significantly (p =
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Fig. 1. Radiofrequency ablation in a rabbit in the radiofrequency group.
A. Computed tomographic section obtained during radiofrequcy ablation. The right lower lobe is penetrated posteriorly by an electrode
along which an ovoid opacity extends (arrows).
B. Contrast-enhanced CT scan obtained after the procedure depicts nonenhancing opacity (arrows) in the central portion of the right
lobe. Note good enhancement of the pulmonary vessels in the area of ablation.
C. Gross specimen demonstrates an 8-mm central zone of coagulation necrosis surrounded by a dark-brown, 1-mm-thick hemorrhagic
rim.
D. Microscopic image of the central ablation zone (A) shows that this contains pyknotic nuclei and eosinophilic cytoplasm, and that hem-
orrhagic congestion (arrows) has occurred at the border between the ablation area and normal pulmonary parenchyma (P).
CD
AB
Table 1. Summary of Maximum Lesion Diameter Induced by
Radiofrequency Ablation
Group Diameter (mean SD, mm) p value
RFA group (n=10) 8.5 1.4 p < .05
SRFA group (n=18)
Acute subgroup (n=10) 12.5 1.6
Subacute subgroup (n=8) 21.3 5.8 p < .05 
Note. RFA=radiofrequency ablation, SRFA=saline-enhanced
radiofrequency ablation,  difference between mean diameter of lesions in
the RFA group and those in the acute subgroup of the SRFA group,  diffe-
rence between mean diameter of lesions in the acute and subacute
subgroups.72), though the type of complication involved depended
on the location of the ablated lesion. Although the inci-
dence rate of pneumothorax (28.6%, 4/14) was not differ-
ent between centrally and peripherally located lesions,
large pneumothoraces (n=3) or hemothorax (n=1) occurred
only in four central lesions (28.6%) adjacent to hilar ves-
sels or bronchi. Major hemorrhage due to electrode pene-
tration of vessels did not occur even where the lesion was
located directly on a vessel.
Imaging and Histopathologic Findings
After RFA, unenhanced CT scanning revealed circum-
scribed hyperattenuated regions extending 5 8 mm from
the portion of the inserted electrode (Fig. 1), while con-
trast-enhanced CT showed no enhancement in the region
of altered pulmonary attenuation. Greater conspicuity of
coagulated tissues was observed at wide window settings
(level=500 HU, width = 2000 HU).
At CT imaging, thermal lesions appeared as hazy opacity
in the soft tissue window (level=50 HU, width=350 HU)
and ranged in diameter from 8 to 19 (mean, 12.6 4.3)
mm (Figs. 1, 2). At CT imaging at a soft-tissue window set-
ting, acute lesions were round or oval-shaped except in re-
gions abutting pulmonary vessels, and there was no signifi-
cant difference in the shape of acute lesions between the
RFA and the SRFA group. However, because of the opaci-
ty related to saline infusion in rabbits in the SRFA group,
the appearance of lesions in the lung window was not well
matched with that of gross specimens. Gross examination
showed that the diameter of an acute lesion, measured as a
central discolored region, was 7 14 (mean, 10.9
1.8)mm, and the thickness of the peripheral rim was 1 2
mm. The mean difference in lesion size, as determined by
CT scanning and pathologic examination, was 3 mm,
which was not statistically significant (p > .05).
Histological examination of an acute lesion revealed a
central charred zone with complete destruction of the
parenchyma, including a small central cavity where tissue
had been lost. Surrounding this were two zones of
eosinophilic coagulative necrosis and a peripheral hemor-
rhagic rim (Figs. 1, 2). There was sharp cut-off between ab-
lated lesions and normal lung. Outside this area, viable
lung containing acute inflammatory cell infiltrate was pre-
sent.
One to two weeks following RFA, surrounding tissue
was becoming organized into granulation tissue, with an
increase of fibroblasts and macrophages and dilatation of
blood vessels at the perimeter of the lesion (Fig. 3). In a le-
sion’s central zone, typical findings of coagulation necrosis
were observed. In centrally located lesions, fibrotic change
was identified in the peribronchial area. At three weeks,
granulation tissue had achieved progressive ingrowth into
the original area of necrosis, and was replacing it, and
there was sharp cut-off between the lesion and normal tis-
sue. The final appearance was of a nodule comprised of
central coagulation necrosis surrounded by a fibrous cap-
sule.
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Fig. 2. Saline-enhanced radiofrequency
ablation in a rabbit in the saline-en-
hanced radiofrequency group.
A. A 17-gauge RF electrode and a 21-
gauge coated Chiba needle have been
placed in the right lower lobe of the lung.
To maximize the effect of saline infusion,
the tip of the needle is positioned 3mm
posterior to the tip of the electrode.
B. Axial CT scan obtained after RF appli-
cation shows a rounded opacity 12 mm
in diameter (arrows), corresponding to
coagulated alveoli and pneumothorax.
C. Gross specimen demonstrates a dark-
brown area of coagulative necrosis sur-
rounded by a peripheral hemorrhagic
rim. Note the somewhat lobulated margin
of the ablation zone, with focal sparing of
the pulmonary artery (arrow).
C
ABDISCUSSION
Lung cancer is among the most commonly occurring ma-
lignancies in the world and is one of the few that continues
to show an increasing incidence (23, 24). Although surgical
resection is acknowledged to be the treatment of choice
and the only therapy with any prospect of cure or long-
term survival, in practice a considerable percentage of pa-
tients with lung cancer are not eligible for surgical inter-
vention due to the advanced stage of the disease, their lim-
ited pulmonary functional reserve, co-morbidities or ad-
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Fig. 3. Follow-up CT scans of a rabbit in the subacute subgroup
obtained through a radiofrequency-ablated lesion both immediately
and two weeks after treatment.
A. CT scan obtained immediately after the procedure depicts a
large opacity involving the right lower lobe of the lung (arrows). 
B. Follow-up CT scan obtained two weeks after the procedure
shows markedly decreased right lung volume, as well as hazy
opacity induced by RFA (arrows). 
C. Microscopic image ( 1) demonstrates marked fibrotic change
involving both the segmental bronchi (arrowheads) of the right low-
er lobe and the ablated lesion (arrows).
D. Microscopic image ( 40) reveals central coagulation necrosis




Table 2. Summary of Complications Related to Radio-Frequency Ablation Procedure
Complication p value
RFA group (n=10)
Central lesions (n=5) Large pneumothorax (n=2)
Peripheral lesions (n=5)
SRFA group (n=18) p = .11
Central lesions (n=9) Large pneumothorax (n=1)
Small pneumothorax (n=1)
Hemothorax (n=1)
Peripheral lesions (n=9) Small pneumothorax (n=4) p = .18   
Abscess (n=1)
Thermal injury to chest wall (n=2)
Note. Difference between incidence rates of complications in the RFA and the SRFA group,  difference between incidence rates
in complications in central and peripheral lesions in the SRFA groupvanced age (25). Those who are not candidates for surgery
can undergo radiation treatment and/or chemotherapy, but
survival prospects increase only modestly and gains are of-
ten accompanied by substantial toxicity, especially in pa-
tients suffering from other co-morbidities (26). Neverthe-
less, the development of nonsurgical and minimally inva-
sive percutaneous techniques for the treatment of lung can-
cer would be advantageous. Effective options might prove
useful for patients with multiple medical problems, co-mor-
bid disease, or concomitant tumor, or for whom surgery
carries high risks.
After encouraging results of RFA in the liver, some re-
searchers have suggested that the procedure could be used
for the treatment of lung malignancies (13 17). The main
advantage of RFA is that it is simple, easy to perform and
offers the option of an indefinite number of repeated appli-
cations. A drawback, however, is that it is often necessary
to overlap ablations by multiple repositioning of the elec-
trode in order to decrease marginal recurrence after RFA
(6). Furthermore, if lung tumors are to be treated by RFA,
the naturally high impedance of air-containing lung tissue
and the risk of pneumothorax related to multiple passes
through the pleura during RFA might be an obstacle to in-
duction of complete tumor necrosis. If these inherent prob-
lems of RFA of lung tumors are to be solved, ablation must
produce a larger coagulation area that could include focal
lung malignancies and some safety margin. Several investi-
gators have demonstrated the possibility of increasing RF
tissue heating and coagulation during RF ablation by alter-
ing electrical and/or thermal conduction through the injec-
tion of saline into the tissues during RF application (18,
19). The present study was conducted to assess the actual
effect of simultaneous infusion of saline during RFA, and
possible resultant complications.
In our study, the mean diameter of RFA lesions in the
saline infusion group was significantly greater than in the
control group: 12.5 mm vs. 8.5 mm (p < .05). In addition,
initial impedance in the SRFA group was significantly low-
er than in the RFA group (p < .05), and tissue impedance
did not change markedly. Thus, in the SRFA group, high-
RF energy instillation over a long period was possible, but
in the RFA group, impedance changed rapidly during the
procedure, frequently inducing activation of the pulsing
technique. Furthermore, impedance was decreased by ad-
ditional infusion of saline during the application of RF en-
ergy. This increases tissue ionicity and decreases tissue im-
pedance, thereby permitting greater current flow, and the
heated liquid spreads thermal energy further and faster
through the tissue than does heat conduction (28, 29).
In this study, an internally cooled electrode was used for
RFA, together with the pulsing technique, and the resultant
lesion was larges than that made by the conventional elec-
trode used in previous studies (21, 27, 30). Nonetheless,
even with an internal cooling mechanism and pulsing tech-
nique, impedance rose rapidly and uncontrollably during
RF energy instillation, inducing frequent pulsing and lead-
ing to restrictions in the size of lesions. After saline infu-
sion, however, the period of RF energy instillation in-
creased, and with it, lesion size. Our results agreed with
those of previous studies of saline-enhanced RFA of the
liver and retroperitoneum (31 33). As demonstrated in
this investigation, an extended volume of coagulation
necrosis due to saline infusion may increase the clinical
utility of RFA therapy by permitting successful treatment
of larger lung tumors or reducing the number of sessions
needed for the treatment of a given tumor. This finding is
of particular importance in the application of RFA to the
treatment of lung cancer, since in order to decrease the oc-
currence of pneumothoraces, electrodes should pass
through the pleura as infrequently as possible. If the inci-
dence of pneumothorax can be reduced, more patients
may benefit from this potentially curative therapy, with its
reduced medical and social costs.
Procedure-related complications arose in 12 cases, com-
prising eight pneumothoraces, two thermal injuries to the
chest wall, one hemothorax, and one lung abscess (Table
2). Their incidence tended to be higher in the SRFA group
(55.6%) than the RFA group (20%), though the difference
was not statistically significant (p = .11). For the peripheral
lesions, however, the complication rates among rabbits in
the SRFA group (77.8%, 7/9) was higher than among
those in the RFA group (0%) (p < .05). The relatively high
incidence rates (28.6%, 8/28) of pneumothorax in this
study were related to the small size of rabbit lung, the rela-
tively large size of the electrodes, and the additional use of
a Chiba needle with an electrode in the SRFA group. We
believe that if the electrode used during RFA is adequate,
permitting simultaneous instillation of saline during RFA in
large animals or in clinical trials, the incidence rates of
pneumothorax could decrease markedly.
Nevertheless, in a clinical setting, these potential prob-
lems require special attention. According to earlier reports
of saline-enhanced RFA (18, 19, 31, 32), direct and uncon-
trollable thermal damage to both adjacent and remote
structures was observed more frequently in the saline infu-
sion group than in the conventional RFA group. To de-
crease this damage, we used a very small amount of saline
(1.5 mL) at a slow infusion rate (approximately 0.05
mL/sec), and it is possible that the two cases of unexpected
thermal injury to the chest wall and diaphragm resulted
from drainage of steam or saline through low-resistance tis-
sue. A further possible drawback of saline-enhanced RFA,
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sions produced may be somewhat irregular in shape, rather
than spherical. However, most ablated lesions in the pre-
sent study were spherical, and we believe that instillation
of a larger amount of saline than we used could be related
to the formation of irregularly shaped lesions.
The clinical role of RFA in the treatment of lung tumors
is still not clear but will undoubtedly evolve. For example,
in patients with hemoptysis or cough in whom radiothera-
py has not controlled the symptoms or cannot be under-
taken due to poor lung function or co-morbidity, this tech-
nique might play a primarily palliative role. We believe
that in lung cancer patients, RF ablation possesses several
potential benefits compared with systemic chemotherapy
or radiotherapy. First, because the therapy is local in na-
ture, it is likely to minimize damage to lung parenchyma
and reduce adverse systemic affects on a patient’s general
health, and for this same reason, RF ablation therapy can
be utilized in patients with limited pulmonary reserve. It is
less likely to have a curative role for stage-I tumors be-
cause many patients with peripheral tumors who have
poor lung function can be offered limited resection, such as
wedge resection or segmentectomy by video-assisted tho-
racoscopic surgery (34 36). However, a randomized trial
of lobectomy versus limited resection for stage-I lung can-
cer showed that the latter did not confer improved periop-
erative morbidity or mortality. Furthermore, even if less
invasive than open surgery, limited resection also requires
general anesthesia (35). There could, therefore, be a role
for RFA as a less invasive alternative to metastasectomy,
but for the present, the greatest clinical utility of RFA may
be in patients with small peripheral lung cancers who are
poor candidates for surgery.
Our study suffered certain limitations. First, the results
obtained in healthy rabbit lung may differ from those ob-
tained with non-small-cell human lung carcinoma.
However, aspects of the process of cell degeneration
caused by the effect of heat on tissue lead us to believe
that the results might well be the same with either normal
lung tissue in rabbits or human lung cancer cells. Second,
rabbit lungs are smaller than the size of the RF ablation
zone that can be produced with the currently available RF
electrode system, and the effectiveness of saline infusion
during RFA may thus not be entirely comparable between
the two groups. In addition, since the 17-gauge electrode
used in this study is too large for rabbits, with their rela-
tively smaller lungs, the complication rates of RFA might
be overestimated.
In conclusion, CT-guided percutaneous transthoracic
RFA with simultaneous hypertonic saline infusion is feasi-
ble, and more effectively produces coagulation necrosis
than RFA without saline infusion. Saline-enhanced RFA
might be a promising technique for the management of in-
operable lung malignancies and has the potential for use as
a minimally invasive approach. To determine whether the
technique can be feasibly and safely used to produce a suf-
ficiently large volume of necrosis to be of value in the
treatment of small peripheral lung tumors in patients for
whom surgery or palliative radiotherapy is unsuitable, fur-
ther study using a larger animal model is warranted.
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